Investigation of the Effectiveness of a Exergame Program in Women With Fibromyalgia
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effects of an exergame-based exercise program and a home-based exercise program in women aged 30-70 years diagnosed with fibromyalgia (FM). The main questions it aims to answer are: Does an exergame-based program using the Nintendo Switch game Ring Fit Adventure improve pain, balance, and functional mobility in women with fibromyalgia? Is the exergame program more effective than a traditional home-based exercise program in improving physical and psychosocial outcomes? Researchers will compare the exergame group and the home-based exercise group to determine whether game-based exercises provide superior benefits in pain reduction, balance, and quality of life. Participants will: Be randomly assigned to either the exergame or the home-based exercise group. Exercise twice a week for four weeks under the supervision of a physiotherapist or via remote monitoring. Undergo evaluations before and after the 4-week training period, and again after a 4-week detraining period. Assessments will include: Pain intensity (Visual Analog Scale) Disease severity (Revised Fibromyalgia Impact Questionnaire, Widespread Pain Index, Symptom Severity Scale, Fibromyalgia Severity Scale) Lower extremity strength (Sit-to-Stand Test) Functional mobility (Timed Up and Go Test) Balance (Single-Leg Stance Test, Berg Balance Scale) Psychosocial status (Cognitive Exercise Therapy Approach Questionnaire - BETY-BQ) Quality of life (Short Form-12) Study findings are expected to provide evidence for the effectiveness of exergame applications as an enjoyable rehabilitation approach for individuals with fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2026
CompletedJanuary 9, 2026
January 1, 2026
3 months
December 12, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Revised Fibromyalgia Impact Questionnaire
The Revised Fibromyalgia Impact Questionnaire will be used to assess the impact of fibromyalgia (FM) on patients. The questionnaire consists of 21 items. All items are based on an 11-point numerical rating scale ranging from 0 to 10, where 10 indicates the worst possible condition. It comprises three domains: function, overall impact, and symptoms. The total score for the function domain (range 0-90) is divided by 3; the overall impact domain (range 0-20) is left unchanged; and the total score for the symptom domain (range 0-100) is divided by 2. The overall Revised Fibromyalgia Impact Questionnaire score is the sum of these three domain scores.
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
Fibromyalgia Severity Scale
The Fibromyalgia Severity Scale is calculated by summing the scores of the Widespread Pain Index (WPI) and the Symptom Severity Scale (SSS). The maximum total score is 31 (19 + 12 = 31). A total score below 12 is generally not considered indicative of fibromyalgia.
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
Secondary Outcomes (7)
Visual Analog Scale (VAS)
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
30-Second Sit-to-Stand Test
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
Timed Up and Go Test
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
Single-Leg Stance Test
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
Berg Balance Scale
Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up
- +2 more secondary outcomes
Study Arms (2)
Exergame group
EXPERIMENTALParticipants in this group will perform exergame-based exercises.
Home-based exercise group
EXPERIMENTALParticipants in this group will perform home-based exercise sessions.
Interventions
Participants in the exergame group will perform exercises using the Nintendo Switch game Ring Fit Adventure under the supervision of a physiotherapist, twice a week for four weeks. The exergame program was designed by a specialist physiotherapist.
Participants in the home-based exercise group will perform exercises prescribed by a specialist physiotherapist as a home program, twice a week for four weeks. The exercises will be taught to participants in face-to-face sessions. Once a week, participants in the home-based exercise group will meet via Zoom to monitor exercise accuracy and progression. The home-based exercise program was adapted from the study conducted by Gentile et al. (2024).
Eligibility Criteria
You may qualify if:
- Women aged between 30 and 70 years, which is an age range in which fibromyalgia (FM) is more prevalent;
- Having a diagnosis of fibromyalgia;
- Being willing to participate in the study and signing the informed consent form;
- Meeting the 2016 American College of Rheumatology (ACR) diagnostic criteria, defined as a Widespread Pain Index (WPI) ≥ 7 and a Symptom Severity Scale (SSS) score ≥ 5, or WPI = 4-6 and SSS ≥ 9.
You may not qualify if:
- Pregnancy or breastfeeding
- Any known advanced pathology related to the locomotor system that contraindicates physical activity (such as arthritis, osteoarthritis, or uric acid disorders)
- Epilepsy
- History of severe headache
- Neurological disorder
- Peripheral neuropathy
- Known severe cardiovascular disease (such as endocranial hypertension, uncontrolled arterial hypertension, heart failure, or presence of a pacemaker)
- Orthopedic disorders of the upper or lower extremities that prevent participation in physical activity
- Rheumatologic disease other than fibromyalgia
- Pneumothorax
- Neoplasia
- Surgery within the last four months
- Severe psychiatric illness (such as uncontrolled depression and anxiety, personality disorders, dementia, or cognitive impairments related to substance abuse)
- Diagnosis of alcohol dependence or use of psychoactive drugs or narcotics
- Participation in any physical activity program within two months prior to the start of the study
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Halic Universitylead
Study Sites (1)
Halic University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gülhan Fetin, PT
Halic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PT, PhD
Study Record Dates
First Submitted
December 12, 2025
First Posted
December 26, 2025
Study Start
December 15, 2025
Primary Completion
February 28, 2026
Study Completion
March 5, 2026
Last Updated
January 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share